News

Palatin reports positive Phase 2 appetite suppression results
Palatin (PTN) announced positive appetite suppression results from its BMT-801 Phase 2 obesity study. The study included a co-administered ...
Indiatimes18d
Hype of weight loss medications: Benefits, risks and what’s often overlooked
Mounjaro (Terzepatide) is a dual GLP-1/GIP (Gastric Inhibitory Peptide) receptor agonist, which may offer better blood sugar control and enhanced weight loss compared to traditional GLP-1 agonists.
OK! Magazine UK18d
Superdrug launches £18 'Botox in a bottle' skincare called 'most affordable on high street'
Serums pack a punch with a potent blend of ingredients, and if you're in the market for just one hero product, we'd suggest the Superdrug Optimum Peptide Serum. According to Superdrug's own trials ...
C&EN24d
Characterization of the Two-Domain Peptide Binding Mechanism of the Human CGRP Receptor for CGRP and the Ultrahigh Affinity ssCGRP Variant
Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824, United States Department of Computational Mathematics, Science and Engineering, Michigan ...
C&EN25d
Discovery of New Difluorocyclobutyl Derivatives as Effective Glucagon-Like Peptide-1 Receptor Agonists with Reduced hERG Inhibitory Activities
Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University, Zhoushan 316021, China ...
Frontiers26d
DKK3 and SERPINB5 as novel serum biomarkers for gastric cancer: facilitating the development of risk prediction models for gastric cancer
1 School of Public Health, Hebei Medical University, Shijiazhuang, China 2 Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China The existing gastric cancer (GC) risk ...